2月27日下午14:00，仁醫(yī)醫(yī)療四人團隊來到柏林夏洛特大學綜合醫(yī)院米特院區(qū)拜訪該院泌尿外科主任Schlomm教授。該院泌尿外科主要病區(qū)設置在本杰明?富蘭克林院區(qū)，而米特院區(qū)主要負責泌尿腫瘤門診和科研工作。會談在米特院區(qū)的Rahel Hirsch轉化醫(yī)學研究中心的泌尿外科會議室進行。該中心由柏林健康研究所（BIH）與夏洛特共同建立，致力于推動基礎研究成果向臨床實踐的轉化。中心位于路易森大街65號，與夏洛特米特院區(qū)主樓相通，經(jīng)過全面翻新，總使用面積達14,875平方米，擁有先進的臨床、實驗室和辦公設施，為科學家和臨床醫(yī)生提供理想的科研平臺。該中心以Rahel Hirsch命名，她是醫(yī)學史上的先驅之一，也是德國的第一位女性醫(yī)學教授。Hirsch教授在生理學和臨床研究領域做出了杰出貢獻，盡管在職業(yè)生涯中面臨諸多挑戰(zhàn)，但她仍堅持不懈地推動科學發(fā)展。以她的名字命名該中心，象征著對醫(yī)學創(chuàng)新和跨學科合作的堅定承諾。在會談中，我們向Schlomm教授介紹了公司的各項運營項目，包括中德訪學項目、中德臨床醫(yī)學博士項目和國際客座教授項目。教授對這些項目表現(xiàn)出濃厚興趣，并表示希望建立一個涵蓋醫(yī)院管理、學科建設和人才培養(yǎng)的良性循環(huán)：通過訪問中國醫(yī)院，合作開展客座教授項目，接收該院博士生，以合作科研項目為博士課題，進行定向聯(lián)合培養(yǎng)。他提到，雖然之前招收過從事基礎研究的中國博士后研究員，但尚未招收過中國博士生。他希望在博士項目中開展轉化研究，這是他和團隊的強項，且能在一兩年內取得成果，更符合中國醫(yī)生的職業(yè)規(guī)劃。會談結束后，我們在醫(yī)院門口合影留念。Schlomm教授還分享了科室的情況：盡管他個人的臨床和研究重點是前列腺癌、基因組學和精準醫(yī)學，但科室設有完善的亞專科，包括小兒泌尿科、腫瘤、尿失禁、性功能障礙、激素紊亂、腎結石、良性前列腺增生、畸形、腎移植和泌尿婦科，是全德國最大的泌尿外科之一。此次交流為未來的合作奠定了堅實基礎，雙方期待在轉化醫(yī)學研究和人才培養(yǎng)方面展開深入合作。

At 2:00 P.M. of February 27th, the team of four from Gloryren arrived at the Campus Charité Mitte (CCM), Charité - University Medicine Berlin to visit Prof. Schlomm, Director of the Department of Urology. The main wards of the Department of Urology are located at the CBF, while the urological oncology clinic and the translational research lab are based at the CCM. The meeting was held in the conference room of the Rahel Hirsch Center for Translational Medicine at the CCM. The center was jointly founded by the Berlin Institute of Health (BIH) and Charité, dedicated to facilitating the translation of basic research findings into clinical practices. The center is located at Luisenstra?e 65, connected to the main building of the CCM, Charité. Completely renovated, it now offers a total of 14,875 square meters of floor space. It provides the scientists and clinicians with state-of-the-art clinical, laboratory, and office space as well as technologies. The center is named after Rahel Hirsch, a pioneer in medical history and the first woman in Germany to be awarded the title of professor of medicine. Prof. Hirsch made remarkable contributions in the fields of physiology and clinical research. Despite facing numerous challenges in her career, she remained steadfast in advancing scientific progress. Naming the center after her symbolizes a strong commitment to medical innovation and interdisciplinary collaboration. During the meeting, the team provided a detailed introduction of the programs that Gloryren is running, including the Sino-German Fellowship Program, the Sino-German MD Program, and the International Visiting Professorship Program. Prof. Schlomm expressed great interests in these programs and proposed establishing a system that integrates exchanges and cooperations in hospital management, speciality construction and talent cultivation. This would involve visiting Chinese hospitals as international visiting professor and accepting MD students from these hospitals, who would work on joint research projects as their doctoral thesis. Prof. Schlomm mentioned that although his team had previously accepted Chinese postdoctoral researchers, they had yet to accept MD students from China. He expressed his intention to conduct translational research in the MD program, which aligns with his team’s expertise and better suits the career plans for Chinese doctors. After the meeting, we took a photo with Prof. Schlomm at the hospital entrance. Prof. Schlomm also shared details about his department, noting that while his personal clinical and research focus is on prostate cancer, genomics, and precision medicine, the department is equipped with well-established subspecialties, including pediatric urology, oncology, incontinence, sexual dysfunction, hormonal disorders, kidney stones, benign prostatic hyperplasia, malformations, kidney transplantation, and urogynecology, making it one of the largest urology departments in Germany. This exchange laid a solid foundation for future collaboration, and we look forward to deepening cooperation in translational research and talent training.